Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa

Digestive Diseases and Sciences

Volumn 45, Issue 9, 2000, Pages 1792-1801

  Lichtenberger, Lenard M ^a,b   Romero, Jimmy J ^a,b   Gibson, George W ^a,b   Blank, Marion A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Bisphosphonates; Hydrophobicity; Phospholipids; Stomach; Ulcer

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PHOSPHATIDYLCHOLINE; RISEDRONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; HYDROPHOBICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH ULCER;

ALENDRONATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DIPHOSPHONATES; ETIDRONIC ACID; GASTRIC MUCOSA; INDOMETHACIN; MALE; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 0033794049     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005574009856     Document Type: Article

References (26)

1. Bisphosphonates: Preclinical aspects and use in osteoporosis
2. Bisphosphonates: Pharmacology and use in treatment of tumor-induced hypercalcemia and metastatic bone disease
3. Multiple ulcerative esophagiris caused by alendronate
4. Pamidronate: An unrecognized problem in gastrointestinal tolerability
5. Esophagitis associated with the use of alendronate
6. Primary amino phosphonates: A new class of gastrotoxic drugs-comparison of alendronate and aspirin
7. Alendronate gastric
8. The effects of amino-versus alkyl-bisphospnonates on the healing of aspirin-induced stomach erosions
9. Comparative study of potential for bisphosphonates to damage gastric mucosa of rats
10. Nonclinical model for assessing gastric effects of bisphosphonates
11. Alendronate induces gastric injury and delays ulcer healing in rodents
12. The gastric mucosal barrier; the hydrophobic lining to the lumen of the stomach
13. The hydrophobic barrier properties of gastrointestinal mucus
14. Surface hydrophobicity of the gastric mucosa in Helicobacter infection: Effect of clearance and eradication
15. Gastric mucosal hydrophobicity in duodenal ulceration: Role of Helicobacter pylori infection density and mucus lipids
16. Attenuation of hydrophobic phospholipid lining is an early event in Helicobacter felis-induced gastritis in mice
17. Does aspirin damage canine gastric mucosa by reducing its surface hydrophobicity?
18. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids; insight into the mechanism and reversal of NSAID-induced gastrointestinal injury
19. Phospholipid- and neutral-lipid containing organelles of rat gastroduodenal mucous cells: Possible origin of the hydrophobic lining
20. Role of surface-active phospholipids in gastric cytoprotection
21. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects
22. A rapid method of total lipid extraction and purification
23. Quantitative analysis of phospholipids by thin layer chromatography and phosphorous analysis of spots
24. Thin-layer chromatography of phospholipids using silica gel without calcium binder
25. Gastric damage with nitrogen-containing bisphosphonates (N-BPs) does not correlate With antiresorptive potency
26. Effect of ammonium ion on the hydrophobic and barrier properties of the gastric mucus gel layer: Implications on the role of ammonium in H. pylori-induced gastritis